NCT07542743
A System to Help With Freezing of Gait in Parkinson's Patients
Not Yet Recruiting · Not Applicable · Barron Associates, Inc. · registry updated 2026-04-21
Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.
The goal of this clinical trial is to learn if the ParkinSense system, a customizable, multimodal, and adaptable cueing system, can assist with freezing of gait (FOG) in patients with Parkinson's disease. The main question it aims to answer is: is the percent of time spent frozen reduced when using the system compared to not using the system? Participants will be asked to take part in a single-visit laboratory study where they will wear the system in a controlled environment, followed by a two weeks of home use.
Inclusion
- Confirmed diagnosis of idiopathic Parkinson's Disease
- Prior identified presence of Freezing of Gait
- Ability to ambulate;
- Montreal Cognitive Assessment (MOCA) MOCA questionnaire score \>=21.
Exclusion
- Peripheral neuropathy
- Severe gait abnormalities not related to Parkinson's Disease.